Dr. Sarah Waheed, MD

Dr. Waheed practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. Waheed's NPI, 1669692406, was assigned on April 26, 2007. Dr. Waheed graduated from King Edward Medical University in 1996. Dr. Waheed's Maryland license number on file is D82240.

Dr. Waheed's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. Waheed's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. Waheed is also affiliated with The Johns Hopkins Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Waheed to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waheed practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Waheed's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Waheed is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Waheed's licenses on file in 3 states: Maryland, District of Columbia and Arkansas.

Dmand AI lists chronic anemia, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Waheed treats.

CMS data shows 463 Medicare services from Dr. Waheed across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $54,654 for them.

CMS counts 127 Medicare patients who saw Dr. Waheed in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Waheed's median patient age at 76, with 48% women.

In 2024, Dr. Waheed wrote 176 Medicare Part D claims for 32 patients. 57% of them were for generic drugs. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $1,217,102 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Waheed for performance year 2024, reported as part of a group. Dr. Waheed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Waheed as offering telehealth.

Dmand AI links 59 papers to Dr. Waheed, published from 2008 to 2017. 2013 was the busiest year, with 12. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Thalidomide. Dr. Waheed has published most often in Blood. Dr. Waheed's most frequent co-authors are Bart Barlogie, MD, Frits Van Rhee, MD and Bijay P. Nair, MD.

CMS Open Payments shows 1 general payment to Dr. Waheed from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $22.

Dr. Waheed graduated from King Edward Medical University in 1996.

Dr. Waheed is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, Cigna and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.